FDA APPROVES NEW MEDICATION FOR DRY EYE DISEASE
FDA APPROVES NEW MEDICATION FOR DRY EYE DISEASE The U.S. Food and Drug Administration approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease,...
View ArticleFDA APPROVES DIFFERIN GEL 0.1% FOR OVER-THE-COUNTER USE TO TREAT ACNE
FDA APPROVES DIFFERIN GEL 0.1% FOR OVER-THE-COUNTER USE TO TREAT ACNE The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the...
View ArticleAVISO DE REGLAMENTACIÓN
AVISO DE REGLAMENTACIÓN Este Reglamento tiene el propósito de establecer las nuevas normas y procedimientos para el uso, posesión, cultivo, manufactura, fabricación, dispensación e investigación...
View ArticleCARRERA 5K CFPR 2016
CARRER 5K CFPR 2016 El viernes 19 de agosto de 2016 se llevará a cabo la carrera 5K en el Conquistador, A Waldorf Astoria Resort en Fajardo, PR. Información e inscripción
View ArticleNUEVO REGLAMENTO SOBRE CANNABIS PARA USO MEDICINAL
NUEVO REGLAMENTO SOBRE CANNABIS PARA USO MEDICINAL Certificación emitida por la oficina del Gobernador Alejandro Garcia Padilla, el pasado 8 de julio de 2016 anunciando un nuevo Reglamento sobre...
View ArticleCDC Issues Updated Zika Recommendations
CDC ISSUES UPDATED ZIKA RECOMMENDATIONS Interim Guidance for healthcare providers caring for pregnant women with possible exposure to Zika virus; Interim Guidance for the prevention of sexually...
View ArticleWARNINGS FOR FLUOROQUINOLONE ANTIBIOTICS
FDA UPDATES WARNINGS FOR FLUOROQUINOLONE ANTIBIOTICS The U.S. Food and Drug Administration approved safety labeling changes for a class of antibiotics, called fluoroquinolones, to enhance warnings...
View ArticleFDA APPROVES ADLYXIN TO TREAT TYPE 2 DIABETES
FDA APPROVES ADLYXIN TO TREAT TYPE 2 DIABETES The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along...
View ArticleCONVOCATORIA
CONVOCATORIAA TODA LA MATRÍCULA DELCOLEGIO DE FARMACÉUTICOS DE PUERTO RICO Esta ASAMBLEA constituye el acto principal de la CONVENCIÓN ANUAL del CFPR que bajo el lema de“Promoviendo el uso adecuado...
View ArticleDEA ANNOUNCES ACTIONS RELATED TO MARIJUANA AND INDUSTRIAL HEMP
DEA ANNOUNCES ACTIONS RELATED TO MARIJUANA AND INDUSTRIAL HEMP The enclosed materials provide the legal and factual bases for our decision, in response to your petitions, regarding the...
View ArticleCDC RELEASES UPDATED VACCINE RECOMMENDATIONS FOR 2016–17 INFLUENZA SEASON
CDC RELEASES UPDATED VACCINE RECOMMENDATIONS FOR 2016–17 INFLUENZA SEASON CDC continues to recommend that everyone aged 6 months and older who does not have contraindications receive a routine...
View ArticleFDA APPROVES ERELZI, A BIOSIMILAR TO ENBREL
FDA APPROVES ERELZI, A BIOSIMILAR TO ENBREL The U.S. Food and Drug Administration today approved Erelzi, (etanercept-szzs) for multiple inflammatory diseases. Erelzi is a biosimilar to Enbrel...
View ArticleFDA REQUIRES STRONG WARNINGS FOR OPIOID ANALGESICS
FDA REQUIRES STRONG WARNINGS FOR OPIOID ANALGESICS, PRESCRIPTION OPIOID COUGH PRODUCTS AND MORE After an extensive review of the latest scientific evidence, the U.S. Food and Drug Administration...
View ArticleEARLY LIFE ANTIBIOTIC USE TIED TO FUTURE ALLERGY RISK
EARLY LIFE ANTIBIOTIC USE TIED TO FUTURE ALLERGY RISK Early life exposure to antibiotics was associated with an increased risk for both hay fever and eczema later in life in a pooled analysis...
View ArticleDACO DA LA BATALLA A LA MARIHUANA SINTÉTICA
DACO DA LA BATALLA A LA MARIHUANA SINTÉTICA Ante la situación, más allá de la respuesta médica para salvar vidas jóvenes, el gobierno inició operativos para tratar de sacar de circulación...
View ArticleMARIJUANA VS. OPIOID OVERDOSES
MARIJUANA VS. OPIOID OVERDOSES In the United States, 25 states have legalized medical marijuana, including 19 that let patients with a prescription buy pot from dispensaries. Proponents argue that...
View ArticleFIRST DRUG FOR DUCHENNE MUSCULAR DYSTROPHY
FDA GRANTS ACCELERATED APPROVAL TO FIRST DRUG FOR DUCHENNE MUSCULAR DYSTROPHY The U.S. Food and Drug Administration today approved Exondys 51 (eteplirsen) injection, the first drug approved to...
View ArticleINDICATIONS FOR ILARIS FOR THREE RARE DISEASES
FDA APPROVES EXPANDED INDICATIONS FOR ILARISFOR THREE RARE DISEASES The U.S. Food and Drug Administration today approved three new indications for Ilaris (canakinumab). The new indications are for...
View ArticleFIRST AUTOMATED INSULIN DELIVERY DEVICE FOR TYPE 1 DIABETES
FIRST AUTOMATED INSULIN DELIVERY DEVICE FOR TYPE 1 DIABETES The U.S. Food and Drug Administration today approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device...
View ArticleIncreasing Number of Compounding Errors Associated with Thyroid Prescriptions
PHARMACISTS MUTUAL RISK MANAGEMENT ALERT: INCREASING NUMBER OF COMPOUNDING ERRORS ASSOCIATED WITH THYROID PRESCRIPTIONS The ability to procure liothyronine in the diluted version has recently...
View Article